Many U.S. doctors believe e-cigs have a role in smoking cessation

doctor's office 300x180Two thirds of American doctors in a small survey believe e-cigarettes can help patients give up smoking and a third recommend them for that purpose.

Researchers asked North Carolina doctors “if they believe e-cigarettes are approved by the FDA for smoking cessation; if they believe e-cigarettes lower the risk of cancer for patients who use them instead of smoking cigarettes; if they believe e-cigarettes are a helpful aid for smoking cessation; and if they recommend use of e-cigarettes to their patients”. Other questions included how often smokers among their patients asked about e-cigs.

The survey found that “two thirds (67%) of the surveyed physicians indicated e-cigarettes are a helpful aid for smoking cessation, and 35% recommended them to their patients”.

The researchers observed that e-cigarettes were more likely to be recommended by doctors who receive many patient enquiries about them, and by older physicians, as well as by – unsurprisingly – those who believe the products carry a lower cancer risk than smoking tobacco.

About two thirds of the doctors believed “that e-cigarettes lower the risk of cancer for patients who use them instead of smoking cigarettes”, and 13% “incorrectly believed that e-cigarettes are already approved by the [U.S. Food and Drug Administration, or FDA] for smoking cessation”.

The 128 respondents from a random sample included 28 family doctors, 24 internal medicine physicians, 21 obstetricians/gynaecologists, 27 psychiatrists, and 28 surgeons.

The study’s authors say that doctors need “widespread dissemination of clear, evidence-based research on e-cigarettes”.

Subscribe to our Newsletter

Join in to hear about news, events, and podcasts in the sector

    See more

    Their paper, “Physicians’ attitudes and use of e-cigarettes as cessation devices, North Carolina, 2013”, was published in the journal PLOS ONE by Kelly L. Kandra from Benedictine University in Lisle, Illinois, along with Leah M. Ranney, Joseph G.L. Lee and Adam O. Goldstein from the University of North Carolina at Chapel Hill.

    They received funding from the North Carolina Department of Health and Human Services, and the National Cancer Institute of the National Institutes of Health.

    What This Means: Research on medical professionals’ attitudes toward e-cigarettes is surprisingly thin on the ground, which makes this welcome despite its narrow focus on doctors in one state who may not be representative of their counterparts across the U.S., let alone internationally. (Indeed, a recent British survey of doctors seems on the surface to have found more scepticism about e-cigs.)

    So, take it with a pinch of salt, and bear in mind that the Public Library of Science (PLOS), which published it, has come in for some criticism of its limited review of articles – essentially, it looks narrowly at their technical qualities rather than assessing their importance.

    But at the very least this raises some interesting issues for future studies to look into, including the varying views of different groups of doctors.

    – Barnaby Page ECigIntelligence staff

    Photo: Mark Wilkie

    Barnaby Page

    Editorial director
    Before joining ECigIntelligence in early 2014 as one of its first employees, Barnaby had a 30-year career as a reporter and editor for newspapers, magazines and online services, working in Canada, the US and the Middle East as well as his current British location. He has edited publications covering fields including technology and the advertising industry, and was launch editor of the first large daily online news service in the British regional media. Barnaby also writes on classical music and film for a number of publications. Barnaby manages the editorial and reporting teams and works closely with the analyst teams, to ensure that all content meets high standards of quality and relevance. He also writes for the site occasionally, mostly on science-related issues, and is a member of the Association of British Science Writers.

    Our Key Benefits

    The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

    ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

    • Stay informed of any legal and market change in the sector that impacts your organisation
    • Maximise resources by getting market and legal data analysis daily in one place
    • Make smart decisions by understanding how the regulatory and market landscape evolves
    • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization